• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于关联和预测研究的遗传风险评估。

Genetic risk assessment based on association and prediction studies.

机构信息

Data Analytics Research Laboratory (DARELab), Institute of Mathematical Sciences and Physics, University of the Philippines Los Baños, 4031, Los Baños, Laguna, Philippines.

Computational Interdisciplinary Research Laboratory (CINTERLabs), University of the Philippines Los Baños, 4031, Los Baños, Laguna, Philippines.

出版信息

Sci Rep. 2023 Sep 14;13(1):15230. doi: 10.1038/s41598-023-41862-3.

DOI:10.1038/s41598-023-41862-3
PMID:37709797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10502006/
Abstract

The genetic basis of phenotypic emergence provides valuable information for assessing individual risk. While association studies have been pivotal in identifying genetic risk factors within a population, complementing it with insights derived from predictions studies that assess individual-level risk offers a more comprehensive approach to understanding phenotypic expression. In this study, we established personalized risk assessment models using single-nucleotide polymorphism (SNP) data from 200 Korean patients, of which 100 experienced hepatitis B surface antigen (HBsAg) seroclearance and 100 patients demonstrated high levels of HBsAg. The risk assessment models determined the predictive power of the following: (1) genome-wide association study (GWAS)-identified candidate biomarkers considered significant in a reference study and (2) machine learning (ML)-identified candidate biomarkers with the highest feature importance scores obtained by using random forest (RF). While utilizing all features yielded 64% model accuracy, using relevant biomarkers achieved higher model accuracies: 82% for 52 GWAS-identified candidate biomarkers, 71% for three GWAS-identified biomarkers, and 80% for 150 ML-identified candidate biomarkers. Findings highlight that the joint contributions of relevant biomarkers significantly influence phenotypic emergence. On the other hand, combining ML-identified candidate biomarkers into the pool of GWAS-identified candidate biomarkers resulted in the improved predictive accuracy of 90%, demonstrating the capability of ML as an auxiliary analysis to GWAS. Furthermore, some of the ML-identified candidate biomarkers were found to be linked with hepatocellular carcinoma (HCC), reinforcing previous claims that HCC can still occur despite the absence of HBsAg.

摘要

表型出现的遗传基础为评估个体风险提供了有价值的信息。虽然关联研究在鉴定人群中的遗传风险因素方面发挥了重要作用,但通过评估个体风险的预测研究来补充这些研究提供了一种更全面的方法来理解表型表达。在这项研究中,我们使用来自 200 名韩国患者的单核苷酸多态性 (SNP) 数据建立了个性化风险评估模型,其中 100 名患者经历了乙型肝炎表面抗原 (HBsAg) 血清清除,100 名患者表现出 HBsAg 高水平。风险评估模型确定了以下两种情况的预测能力:(1)全基因组关联研究 (GWAS) 确定的候选生物标志物在参考研究中被认为具有显著意义,(2)机器学习 (ML) 确定的候选生物标志物,这些标志物通过使用随机森林 (RF) 获得了最高的特征重要性评分。虽然使用所有特征可以达到 64%的模型准确性,但使用相关生物标志物可以获得更高的模型准确性:52 个 GWAS 确定的候选生物标志物的准确性为 82%,3 个 GWAS 确定的生物标志物的准确性为 71%,150 个 ML 确定的候选生物标志物的准确性为 80%。研究结果表明,相关生物标志物的共同贡献显著影响表型出现。另一方面,将 ML 确定的候选生物标志物与 GWAS 确定的候选生物标志物结合在一起,可以将预测准确性提高到 90%,这表明 ML 作为 GWAS 的辅助分析具有一定的能力。此外,一些 ML 确定的候选生物标志物与肝细胞癌 (HCC) 有关,这进一步证实了尽管没有 HBsAg,HCC 仍然可能发生的说法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaf/10502006/e57f6024c633/41598_2023_41862_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaf/10502006/db2ca9b6a85d/41598_2023_41862_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaf/10502006/11c6989dd8a3/41598_2023_41862_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaf/10502006/e57f6024c633/41598_2023_41862_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaf/10502006/db2ca9b6a85d/41598_2023_41862_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaf/10502006/11c6989dd8a3/41598_2023_41862_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaf/10502006/e57f6024c633/41598_2023_41862_Fig3_HTML.jpg

相似文献

1
Genetic risk assessment based on association and prediction studies.基于关联和预测研究的遗传风险评估。
Sci Rep. 2023 Sep 14;13(1):15230. doi: 10.1038/s41598-023-41862-3.
2
A machine learning-based SNP-set analysis approach for identifying disease-associated susceptibility loci.基于机器学习的 SNP 集分析方法,用于鉴定与疾病相关的易感性基因座。
Sci Rep. 2022 Sep 22;12(1):15817. doi: 10.1038/s41598-022-19708-1.
3
A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance.乙型肝炎表面抗原血清学清除后肝细胞癌风险预测模型。
J Hepatol. 2022 Sep;77(3):632-641. doi: 10.1016/j.jhep.2022.03.032. Epub 2022 Apr 7.
4
Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.全基因组关联研究鉴定出 TLL1 变异与丙型肝炎病毒感染清除后肝细胞癌发展相关。
Gastroenterology. 2017 May;152(6):1383-1394. doi: 10.1053/j.gastro.2017.01.041. Epub 2017 Feb 3.
5
Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearance.乙肝 e 抗原血清学转换后乙型肝炎表面抗原血清学清除患者的肝细胞癌和长期结局及预测评分。
Hepatology. 2018 Aug;68(2):462-472. doi: 10.1002/hep.29874. Epub 2018 Jun 6.
6
Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.年龄和性别对乙肝表面抗原血清学清除后肝细胞癌风险的影响。
J Hepatol. 2017 Nov;67(5):902-908. doi: 10.1016/j.jhep.2017.06.019. Epub 2017 Jun 24.
7
Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.HBsAg 血清学清除对乙型肝炎病毒相关肝细胞癌切除术后晚期复发的影响。
J Hepatol. 2022 Oct;77(4):939-946. doi: 10.1016/j.jhep.2022.05.014. Epub 2022 May 26.
8
HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.HBsAg 血清学清除在核苷(酸)类似物实现完全病毒抑制后进一步降低肝细胞癌风险。
J Hepatol. 2019 Mar;70(3):361-370. doi: 10.1016/j.jhep.2018.10.014. Epub 2018 Oct 25.
9
Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance.系统评价与荟萃分析:乙型肝炎表面抗原血清学清除的慢性乙型肝炎患者中肝细胞癌的发生。
Aliment Pharmacol Ther. 2016 Jun;43(12):1253-61. doi: 10.1111/apt.13634. Epub 2016 Apr 27.
10
Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.联合病毒标志物对乙型肝炎病毒 e 抗原阴性携带者进行肝细胞癌风险分层。
J Infect Dis. 2013 Aug 15;208(4):584-93. doi: 10.1093/infdis/jit209. Epub 2013 May 8.

引用本文的文献

1
The classification method of donkey breeds based on SNPs data and machine learning.基于单核苷酸多态性(SNP)数据和机器学习的驴品种分类方法
Front Genet. 2025 Apr 9;16:1496246. doi: 10.3389/fgene.2025.1496246. eCollection 2025.
2
Diagnostic performance of AI-based models versus physicians among patients with hepatocellular carcinoma: a systematic review and meta-analysis.基于人工智能的模型与医生对肝细胞癌患者的诊断性能:一项系统评价和荟萃分析
Front Artif Intell. 2024 Aug 19;7:1398205. doi: 10.3389/frai.2024.1398205. eCollection 2024.
3
Temporal Trends in the Completeness of Epidemiological Variables in a Hospital-Based Cancer Registry of a Pediatric Oncology Center in Brazil.

本文引用的文献

1
Dealing with dimensionality: the application of machine learning to multi-omics data.处理维度问题:机器学习在多组学数据中的应用。
Bioinformatics. 2023 Feb 3;39(2). doi: 10.1093/bioinformatics/btad021.
2
A machine learning-based SNP-set analysis approach for identifying disease-associated susceptibility loci.基于机器学习的 SNP 集分析方法,用于鉴定与疾病相关的易感性基因座。
Sci Rep. 2022 Sep 22;12(1):15817. doi: 10.1038/s41598-022-19708-1.
3
LncRNA PCED1B-AS1 Upregulation in Hepatocellular Carcinoma and Regulation of the miR-10a/BCL6 Axis to Promote Cell Proliferation.
巴西儿科肿瘤中心医院癌症登记处流行病学变量完整性的时间趋势。
Int J Environ Res Public Health. 2024 Feb 9;21(2):200. doi: 10.3390/ijerph21020200.
长链非编码 RNA PCED1B-AS1 在肝癌中的上调及其对 miR-10a/BCL6 轴的调控促进细胞增殖。
Crit Rev Eukaryot Gene Expr. 2022;32(6):11-20. doi: 10.1615/CritRevEukaryotGeneExpr.2022039954.
4
Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg).乙肝病毒感染患者中的肝细胞癌及乙肝表面抗原(HBsAg)的作用
J Clin Med. 2022 Feb 21;11(4):1126. doi: 10.3390/jcm11041126.
5
PIP-SNP: a pipeline for processing SNP data featured as linkage disequilibrium bin mapping, genotype imputing and marker synthesizing.PIP-SNP:一种用于处理SNP数据的流程,其特点是连锁不平衡区间映射、基因型填充和标记合成。
NAR Genom Bioinform. 2021 Jul 5;3(3):lqab060. doi: 10.1093/nargab/lqab060. eCollection 2021 Sep.
6
Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson's disease using machine learning.使用机器学习研究特发性帕金森病中 SNCA 基因与认知能力的关系。
Sci Rep. 2021 Mar 1;11(1):4917. doi: 10.1038/s41598-021-84316-4.
7
Revisiting the genome-wide significance threshold for common variant GWAS.重新审视常见变异 GWAS 的全基因组显著阈值。
G3 (Bethesda). 2021 Feb 9;11(2). doi: 10.1093/g3journal/jkaa056.
8
Association is not prediction: A landscape of confused reporting in diabetes - A systematic review.关联不等同于预测:糖尿病领域中混淆不清的报告现状——一项系统性综述。
Diabetes Res Clin Pract. 2020 Dec;170:108497. doi: 10.1016/j.diabres.2020.108497. Epub 2020 Oct 15.
9
Prediction Model of HBsAg Seroclearance in Patients with Chronic HBV Infection.慢性乙型肝炎病毒感染者 HBsAg 血清学清除预测模型。
Biomed Res Int. 2020 Aug 14;2020:6820179. doi: 10.1155/2020/6820179. eCollection 2020.
10
From GWAS to Function: Using Functional Genomics to Identify the Mechanisms Underlying Complex Diseases.从全基因组关联研究到功能研究:利用功能基因组学确定复杂疾病的潜在机制。
Front Genet. 2020 May 13;11:424. doi: 10.3389/fgene.2020.00424. eCollection 2020.